Teva Pharmaceutical Industries TEVA
NYSE TEVA
$39.82 +0.94 (+2.42%)
As of: Sep 29, 2026 · 3:59 PM EDT

Teva Pharmaceutical Industries (TEVA) Notes Payables (2009 - 2017)

Updated

Teva Pharmaceutical Industries (TEVA) posted Notes Payables of $1 million for Q4 2017, down 93.3% from $15 million a year earlier.

Analysis

Teva Pharmaceutical Industries (TEVA) Notes Payables (2009 - 2017) Analysis & Trends

Since Q4 2009, Teva Pharmaceutical Industries has reported Notes Payables for 8 quarters.

  • Annual Notes Payables shows a three-year compound annual growth rate of -72.1% (FY2014 to FY2017).
  • In prior years, Teva Pharmaceutical Industries' Notes Payables was $15 million in FY2016 (-80.0%), $75 million in FY2015 (+63.0%) and $46 million in FY2014.
  • The Q4 2017 figure stands as the lowest quarterly Notes Payables in data going back to Q4 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Teva Pharmaceutical Industries 45.31 Bn 32.16 Bn 2.15 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 1.00 Mn
Dec 31, 2016 15.00 Mn
Mar 31, 2016 26.00 Mn
Dec 31, 2015 75.00 Mn
Dec 31, 2014 46.00 Mn
Dec 31, 2011 2.59 Bn
Dec 31, 2010 742.00 Mn
Dec 31, 2009 95.00 Mn
API Access

Teva Pharmaceutical Industries Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=TEVA&period=max&api_key=YOUR_API_KEY